Alentis Therapeutics Archives

Jeito Capital Leads a $105 Million Series C Financing in Alentis Therapeutics to Advance Transformational Medicines for Claudin-1 in Cancer & Fibrosis

Paris, France, April 13 (Korea Bizwire) - Jeito Capital (“Jeito”), the largest fully independent private equity firm dedicated to healthcare and biopharma in Europe, announced today that it has led a $105 million (€96 million) Series C financing in Alentis Therapeutics (“Alentis” or the “Company”), a clinical-stage biotech spun out of INSERM, based in Basel (Switzerland) with [...]

Jeito Capital Becomes Key Investor in Alentis Therapeutics as Part of $67 Million Series B Financing Round

Paris, France, June 15 (Korea Bizwire) – Jeito Capital (“Jeito”), a rapidly emerging independent Private Equity firm dedicated to biotech and biopharma, today announces that it has become a key investor as part of a $67 million Series B financing round in Alentis Therapeutics (Alentis). The Swiss biotech company, a spin-off of French Inserm with R&D in [...]